申请人:NovaSaid AB
公开号:EP2495244A1
公开(公告)日:2012-09-05
A compound of formula (I):
as well as pharmaceutically acceptable salts thereof, and a pharmaceutical composition comprising the compound. The compound is useful for the treatment of disorder selected from inflammatory diseases, pain, auto-immune disease, breathing disorders, fever, cancer, inflammation related anorexia, overactive bladder, familial adenomatous polyposis (FAP) condition, neurodegenerative diseases, bone diseases and cardiovascular diseases.
式 (I) 的化合物:
及其药学上可接受的盐类,以及包含该化合物的药物组合物。该化合物可用于治疗选自炎症性疾病、疼痛、自身免疫性疾病、呼吸障碍、发热、癌症、与炎症相关的厌食症、膀胱过度活动症、家族性腺瘤性息肉病(FAP)、神经退行性疾病、骨病和心血管疾病的疾病。